Le Lézard
Classified in: Covid-19 virus
Subject: SVY

Worldwide Aliphatic Hydrocarbon Solvents and Thinners Industry to 2027 - Impact of COVID-19 on the Market


DUBLIN, July 13, 2020 /PRNewswire/ -- The "Aliphatic Hydrocarbon Solvents and Thinners - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Amid the COVID-19 crisis, the global market for Aliphatic Hydrocarbon Solvents and Thinners estimated at US$4.8 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027. Varnish Makers & Painter`s Naphtha, one of the segments analyzed in the report, is projected to grow at a 5.7% CAGR to reach US$2.9 Billion by the end of the analysis period.

After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mineral Spirits segment is readjusted to a revised 3% CAGR for the next 7-year period. This segment currently accounts for a 21.5% share of the global Aliphatic Hydrocarbon Solvents and Thinners market.

The U.S. Accounts for Over 27.1% of Global Market Size in 2020, While China is Forecast to Grow at a 7.2% CAGR for the Period of 2020-2027

The Aliphatic Hydrocarbon Solvents and Thinners market in the U. S. is estimated at US$1.3 Billion in the year 2020. The country currently accounts for a 27.1% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.4 Billion in the year 2027 trailing a CAGR of 7.3% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR while Rest of European market (as defined in the study) will reach US$1.4 Billion by the year 2027.

Hexane Segment Corners a 14.9% Share in 2020

In the global Hexane segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$545 Million in the year 2020 will reach a projected size of US$729.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$873.5 Million by the year 2027, while Latin America will expand at a 5.7% CAGR through the analysis period. The publisher brings years of research experience to this 7th edition of our report. The 293-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Total Companies Profiled: 38

For more information about this report visit https://www.researchandmarkets.com/r/rdr17u

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 19:30
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:51
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...

at 17:20
Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive...

at 16:45
Dogness (International) Corporation ("Dogness" or the "Company") , a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced its financial results for the six months ended December...

at 16:25
Inseego Corp. (the "Company"), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, and SMBs, announced today that as a result of its improving liquidity position and financial results,...



News published on and distributed by: